NME6 antibody (AA 1-100)
Quick Overview for NME6 antibody (AA 1-100) (ABIN872512)
Target
See all NME6 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1-100
-
Purpose
- NME6 Polyclonal Antibody
-
Predicted Reactivity
- Human,Mouse,Rat,Dog,Cow,Sheep,Horse
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human NME6/IPIA ALPHA
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- NME6 (NME/NM23 Nucleoside Diphosphate Kinase 6 (NME6))
-
Alternative Name
- NME6
-
Background
-
Synonyms: Inhibitor of p53 induced apoptosis alpha, Inhibitor of p53-induced apoptosis-alpha, IPIA ALPHA, IPIA-alpha, NDK 6, NDK6_HUMAN, NDP kinase 6, NM23 H6, nm23-H6, NM23H6, Nme6.
Background: Major role in the synthesis of nucleoside triphosphates other than ATP. The ATP gamma phosphate is transferred to the NDP beta phosphate via a ping-pong mechanism, using a phosphorylated active-site intermediate. Inhibitor of p53-induced apoptosis.Tissue specificity: Expressed at a moderately low level in many tissues. Most abundant in kidney, prostate, ovary, intestine, and spleen.
-
Gene ID
- 10201
-
Pathways
- Nucleotide Phosphorylation, Ribonucleoside Biosynthetic Process
Target
-